In T-ALL, aberrantly activated TAL1 is dependent on E2A and HEB for malignant transformation, because as a class II bHLH, TAL1 must heterodimerize with E2A or HEB in order to bind E boxes in its target enhancers26. This evidence concerns the gene TAL1 and acute lymphoblastic leukemia.